Metoprololtartrat Heumann

Metoprolol tartrate, the active ingredient in Metoprololtartrat Heumann, is a beta‑blocker presented as an oral tablet for oral use. It is used to treat hypertension, angina, post‑myocardial‑infarction care, chronic heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprololtartrat Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol tartrate acts on the cardiovascular system to control blood pressure and heart workload.

Hypertension: lowers systolic and diastolic pressure by reducing heart rate and contractility. Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. Post‑myocardial infarction: improves survival by limiting ventricular remodeling. Chronic heart failure: enhances left‑ventricular function and reduces hospitalization risk. Cardiac arrhythmias: stabilises heart rhythm by slowing conduction through the AV node.

Metoprolol tartrate may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal pain) - Sleep disturbances or vivid dreams

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in asthmatic patients - Acute decompensated heart failure - Allergic reactions (rash, angioedema) - Depression or mood changes

Before prescribing Metoprolol tartrate, clinicians should evaluate patient-specific factors. - Cardiac assessment: confirm baseline heart rate and blood pressure. - Monitor regularly: check vital signs and ECG during dose adjustments. - Respiratory caution: use carefully in patients with asthma or COPD. - Discontinuation: avoid abrupt withdrawal to prevent rebound tachycardia. - Dose adjustment: consider renal or hepatic impairment when titrating. - Store at ambient temperature: keep in the original container, protect from moisture.

Metoprolol tartrate can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol) - Calcium‑channel blockers verapamil or diltiazem - Clonidine (abrupt discontinuation may cause hypertension) - Insulin or oral hypoglycemics (mask hypoglycemia symptoms) - Monoamine‑oxidase inhibitors (risk of severe hypotension)

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs (enhanced hypotensive effect) - Diuretics (potentiates blood pressure lowering) - Antidepressants (SSRIs, SNRIs) may increase bradycardia risk - Lithium (possible increase in serum levels) - NSAIDs (may reduce antihypertensive efficacy)